Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

The Accepted Marketing Application of Roche's Glofitamab in China

Yefenghong/PharmaSourcesMarch 01, 2023

Tag: Glofitamab , Bispecific Antibody , CD20/CD3

PharmaSources Customer Service